Special Edition #AIEye: How #ArtificialIntelligence ( #AI) is Tracking, Modeling and Providing Medical Info #Coronavirus (OTC: $GTCH) (NASDAQ: $NVDA) (NYSE: $IBM) (NASDAQ: $MSFT)
Point Roberts WA, Vancouver BC – March 24, 2020 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye which looks at how AI is playing a leading role in tracking, modeling and providing general medical information as well as information on the coronavirus, featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).
Read this news featuring GTCH in full at https://www.investorideas.com/news/2020/artificial-intelligence/03241AIEye-GTCH-NVDA-IBM-MSFT.asp
Taiwan, one of the countries that got it right according to a recent article by Stanford Health Policy, used AI, big data and analytics to track and manage the disease in combination with proactive testing.
“Taiwan’s government learned from its 2003 SARS experience and established a public health response mechanism for enabling rapid actions for the next crisis.”
ABC news reported, “Audrey Tang, Taiwan's digital minister and the youngest minister without portfolio to hold office, utilized artificial intelligence to harness data and created real-time digital updates to alert citizens of risky areas to avoid and a live map of local supplies of face masks.”
Currently (as of March 22, 2020) Taiwan has 169 cases, 2 deaths and 28 recovered.
The US is now following a similar path, with tech leaders and government turning to AI for solutions, with initiatives including the COVID-19 Open Research Dataset (CORD-19).
Smaller companies like GBT Technologies, Inc. (OTCPINK:GTCH) an emerging technology company focusing on artificial intelligence innovations and chip design was directing research and development resources into healthcare and medicine prior to the pandemic, using the company’s Avant! AI licensed technology (https://www.avant-ai.net) and introducing as “derivative” a new tool - https://www.hmd.care as beta version.
In a previous interview with Investor Ideas, CTO Danny Rittman explained how Avant!, powered by cooperation with Costa Rica developers works: "Our goal is to implement a fundamental part of human intelligence called relational reasoning, which is planned to enable Avant! to acquire expertise on its own by understanding object's relations. Avant! will include an advanced artificial neural network (ANN) capable of pattern recognition and reasoning about those patterns which is very similar to the human brain. Rather than operating on pre-set rules, the system will learn image's patterns by tweaking the relations between objects, analyzing connections, and building hypotheses about how they relate to each other. This capability will be used for Avant! imaging system for upcoming implementation in the medical field. We are creating an interactive and intuitive intelligent system that performs complex computation over discrete entities and the relations between them. Our goal is to provide Avant! a broad range of advantages and capabilities when it comes to intelligent imaging, especially in the medical domain."
Building on its healthcare applications, a new development from the team at Costa Rica is the launch of Hippocrates – its new AI-based medical advisor (https://www.hmd.care). Hippocrates health system is an AI-based medical advisor. Users may provide symptoms, ask medical questions and describe conditions in order to get diagnosis advice including known medications and treatments. This means a reliable, simple and fast medical assistance experiences for people around the world. It provides the essential capabilities necessary to advise patients about medical symptoms and conditions based on data and analytics taken from The National Center for Biotechnology, CDC and other accredited resources. The system is now in testing phase and has been trained to support basic health information. The team will evaluate the system for the next few months, targeting it to ultimately becoming an expert in a specific area, for example, respiratory or cardiovascular diseases. The service is available for adults (18+) under a disclaimer and is not intended to replace a human physician.
According to IBM ( NYSE: IBM), “Watson Health unit is working directly with health organizations around the world to better understand the nature of COVID-19. The IBM Clinical Development system has been made available without charge to national health agencies to reduce the time and cost of clinical trials by providing data and analysis from web-enabled devices.”
“And our cognitive Operational Risk Insight tool has been made available to not-for-profit organizations, charged with information about the virus spread.”
IBM also reported, “US Department of Energy’s Oak Ridge National Laboratory (ORNL) has deployed the world’s most powerful and smartest supercomputer, IBM built Summit, in the fight against COVID-19.”
(NASDAQ: NVDA) reported, “At the epicenter of the Coronavirus in Wuhan China, a team of physicians at the Zhongnan Hospital are using GPU-accelerated AI software to detect visual signs of the coronavirus (Covid 19).”
“Physicians there say the AI-based software, which relies on NVIDIA GPUs for both training and inference, has helped overworked staff screen patients and prioritize those likely to have the virus.”
“The software, developed by Beijing-based startup Infervision, a member of the NVIDIA Inception, NVIDIA’s startup accelerator program, can identify typical signs or partial signs of Covid 19 infection. To do this, Infervision’s software detects signs of pneumonia caused by the virus.”
“Once the outbreak began, the company quickly fine-tuned their existing pneumonia models to look more closely at coronavirus pneumonia.”
The White House, realizing how AI can play an integral role in finding solutions, issued a press release on March 16th, ‘Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset’.
From the news – “Today, researchers and leaders from the Allen Institute for AI, Chan Zuckerberg Initiative (CZI), Georgetown University’s Center for Security and Emerging Technology (CSET), Microsoft (NASDAQ: MSFT) and the National Library of Medicine (NLM) at the National Institutes of Health released the ‘COVID-19 Open Research Dataset (CORD-19’) of scholarly literature about COVID-19, SARS-CoV-2, and the Coronavirus group.”
“Now, the White House joins these institutions in issuing a call to action to the Nation’s artificial intelligence experts to develop new text and data mining techniques that can help the science community answer high-priority scientific questions related to COVID-19.”
“The collection was constructed via a unique collaboration between Microsoft, NLM, CZI, and the Allen Institute for AI, coordinated by Georgetown University. Microsoft’s web-scale literature curation tools were used to identify and bring together worldwide scientific efforts and results, CZI provided access to pre-publication content, NLM provided access to literature content, and the Allen AI team transformed the content into machine-readable form, making the corpus ready.”
As the global race continues to track, manage and find solutions for the coronavirus, AI can move rapidly, analyze data, map and provide medical information and updates to the world as vaccines are being developed. AI is currently on a path to replace dogs as man’s best friend; at least for the short term.
To get current numbers by country on the Coronavirus visit: Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE)
For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: GTCH is a paid monthly featured company for news and social media on Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.aspLearn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com
Contact Investorideas.com
800 665 0411
 |  |
No comments:
Post a Comment